This study evaluated children who presented to 20 emergency departments across the United States to determine whether pretreatment with antibiotics correlated with different cerebrospinal fluid (CSF) ...
Summit™ 2.0 is a CSF-based liquid biopsy assay designed to enable comprehensive genomic profiling for characterization of CNS tumors. CNS malignancies present unique diagnostic challenges, as ...
In clinical research, a first-time finding may rouse intrigue, but it’s generally independent confirmations of the data that give them potential to leave an indelible mark. That’s why a study of ...
The MarketWatch News Department was not involved in the creation of this content. Validation Data on 118 Patients Published in Cancers CHICAGO, Feb. 18, 2026 /PRNewswire/ -- Belay Diagnostics, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results